Post-diagnostic low-dose zinc supplem... - Advanced Prostate...

Advanced Prostate Cancer

21,449 members26,870 posts

Post-diagnostic low-dose zinc supplement use among nonmetastatic associated with lower risk of lethal PCa and all-cause mortality.

Graham49 profile image
2 Replies

Post-diagnostic Zinc Supplement Use and Prostate Cancer Survival Among Men With Nonmetastatic Prostate CancerYiwen Zhang, Konrad H Stopsack, Kana Wu, Mingyang Song, Lorelei A Mucci, Edward Giovannucci

The Journal of Urology, 10.1097/JU. 0000000000003080, 2022

Purpose:

Biological and experimental evidence support restoration of normal zinc levels in malignant prostate cells as a promising prostate cancer treatment, yet the influence of zinc supplementation after diagnosis on prostate cancer survival in a human population is unknown.

Materials and Methods:

We prospectively assessed post-diagnostic zinc supplementation in relation to prostate cancer survival among 5,788 men with nonmetastatic prostate cancer in the Health Professionals Follow-up Study (1986-2019). We used Cox regression models to estimate the multivariable hazard ratios and 95% confidence intervals of lethal prostate cancer (distant metastases or prostate cancer–specific death) and all-cause mortality according to post-diagnostic zinc supplement use and dosage.

Results:

During a median follow-up of 11 years, we documented 527 lethal prostate cancer events and 3,198 all-cause deaths. Fifteen percent of men reported zinc supplement use post-diagnosis. Compared to nonusers, post-diagnostic zinc supplement use was associated suggestively with a lower risk of lethal prostate cancer (HR [95% CI], 0.82 [0.60-1.13]) and significantly with all-cause mortality (0.84 [0.74-0.96]). The inverse association was mostly observed among men who used post-diagnostic zinc supplements of 1-24 mg/d (lethal prostate cancer: 0.55 [0.32-0.96]; all-cause mortality: 0.77 [0.64-0.93]), while higher dosage did not show a lower risk.

Conclusions:

Post-diagnostic low-dose zinc supplement use among nonmetastatic prostate cancer patients was associated with lower risk of lethal prostate cancer and all-cause mortality. A potential benefit of low-dose post-diagnostic zinc supplement for prostate cancer survival merits further study.

Written by
Graham49 profile image
Graham49
To view profiles and participate in discussions please or .
Read more about...
2 Replies
Nusch profile image
Nusch

I‘m supplementing Zinc, too. Thx for your post! Main reason, why I decided for Zinc supplementation: You can monitor your daily intake with apps such as Cronometer. It gives you all the details. So I learned, that I‘m short on Zinc, Iodine and Calcium, based on my whole food plant based diet. I started supplementing these three couple of months ago and feel much better and stronger now. Also got faster on my daily runs.

Jalbom49 profile image
Jalbom49

great that you are supplementing zink. But you can develop copper deficiency.

Best is a supplement that contains copper and zink. I get zink from red meat but when I feel the beginnings of a sore throat I use zink lozenges with great results.

You may also like...

Study shows supplement successfully fights lethal prostate cancer

5,182 men from 1986 to 2012. The conclusion is: „Alcohol drinkers had a lower risk of lethal...

Maybe we should all get a cholera vaccine.

\\" \\"Risk of death due to all the causes \\"In Table 3, we show the risk of overall mortality...

Interesting report on the efficacy of IMRT on prostate cancer

intermediate-risk prostate cancer and 91.3% for high-risk prostate cancer. The 5-year survival...

Supplementing Vitamin D may contribute to cancer mortality

excluding all men with prostate cancer), D-Health did not exclude men with prostate cancer from...

High Gleason low PSA - quit ADT?

to increase survival: ADT was associated with 13% decreased risk of death from any cause when PSA...